News and Educations

EMA to review certain injectable medicines for treatment of acute allergic reactions

02.12.2016

Recommendations for reporting variations in medicinal product documentation based on the safety signal review from the PRAC October 2016 meeting

21.11.2016

Meeting highlights from the CMDh meeting in November 2016

16.11.2016

Newly approved medicinal products

15.11.2016

The list of newly approved medicinal products for the period between 1st October 2016 and 31st October 2016 is available in the continuation of this notice.

Meeting highlights from the CHMP meeting in November 2016

14.11.2016

Notice of possible unavailability of HALMED's online applications, e-mail addresses and phone numbers

10.11.2016

Direct healthcare professional communication on the new important advice regarding suicidal ideation and behaviour with use of apremilast (Otezla)

08.11.2016

Direct healthcare professional communication on the new important advice regarding viral reactivation with use of lenalidomide (Revlimid)

08.11.2016

Meeting highlights from the PRAC meeting in October 2016

28.10.2016

Recommendations for reporting variations in medicinal product documentation based on the safety signal review from the PRAC September 2016 meeting

27.10.2016

For Patients and Public

For Health Care Professionals

For Industry Representatives